Results 101 to 110 of about 31,480,937 (161)

Identification of the Novel HLA-E*01:157 Allele by Next-Generation Sequencing. [PDF]

HLA
Dong L, He Y, Pi W, Chen N, Zhu F.
europepmc   +1 more source

A fully human pan VL9 HLA-E TCRm antibody enables functional dissection of HLA-E biology and checkpoint signaling. [PDF]

iScience
Ghaffari S, Upchurch-Ange K, Oter G, Tripathi T, Gimlin S, Wawro Weidanz D, Middelburg J, van Hall T, Weidanz JA.   +8 more
europepmc   +1 more source

The complex HLA-E-nonapeptide in Behçet disease. [PDF]

Front Immunol, 2023
Castaño-Núñez ÁL, Montes-Cano MA, García-Lozano JR, Ortego-Centeno N, García-Hernández FJ, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, Gómez de la Torre R, Fanlo P, Rodríguez-Carballeira M, Rodríguez-Rodríguez L, Camps T, Castañeda S, Alegre-Sancho JJ, Martín J, González-Escribano MF.   +20 more
europepmc   +1 more source

The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective. [PDF]

Clin Cancer Res
López-Botet M, Vilches C, Muntasell A.
europepmc   +1 more source

NKG2A-HLA-E and TIM3-galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma. [PDF]

Cancer Immunol Immunother
Lin Y, Feng W, Li Y, Tang Y, Zhuang X, Huang Y, Xie J, Liu K, Fan Y, Tang Y, Li D, He Z, Qiu Y, Chen J, Xu J, Yang Z, Lan L, Tang D, Deng G, Zhou G.   +19 more
europepmc   +1 more source

RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation. [PDF]

Sci Adv
De Silva P, Fitzgerald S, Cazaubiel J, Qian K, Hofree M, Lin JR, Pelletier R, Lopez Leon M, Ho PVM, Takashima Y, Väyrynen JP, Matsuda K, Ugai T, Ford-Roshon D, Bala P, Hacohen N, Ng K, Nowak JA, Ogino S, Sorger PK, Giannakis M.   +20 more
europepmc   +1 more source

Multifunctional-engineered NK cells overcome tumor immunosuppression by combining PD-L1 and HLA-E targeting and endogenous IL15 production. [PDF]

Signal Transduct Target Ther
Fiore PF, Forcelloni S, Moretta L, Assenza MR, Orecchia P, Bilotta MT, Machwirth M, Shpati T, Sanvi LW, Haas D, Vitozzi S, Giansanti M, Nazio F, Tumino N, Caruana I, Vacca P.   +15 more
europepmc   +1 more source

HLA-E single-chain trimer shields gene-edited allogeneic CAR T cells from NK cell attack. [PDF]

Blood Adv
Apodaca KM, Xu C, Stanton KL, Baroja ML, Alfaro Doblado AR, Engel NW, Wellhausen N, Cox A, Berjis A, Ji M, Bushara O, Perez DM, Welch C, Banerjee E, Assenmacher CA, Sheppard NC, Scholler J, June CH, Carreno BM, Linette GP.   +19 more
europepmc   +1 more source

Herpesvirus-host interactions in neurological diseases: the immunogenetic role of HLA-E. [PDF]

J Virol
Graninger M, Puchhammer-Stöckl E, Vietzen H.   +2 more
europepmc   +1 more source

Integrated Single-Cell Transcriptomics Identifies γδ T-Cell Heterogeneity and a Candidate HLA-E-NKG2A Regulatory Axis in Pancreatic Ductal Adenocarcinoma. [PDF]

Cancers (Basel)
Mandal S, Hasan SR, Dhali A, Maji M.
europepmc   +1 more source